Skip to main content
Tue, Apr 7, 2026
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
Sample data
ScienceUnited States1 sourcesNeutral

Neurocrine agrees acquisition of Soleno Therapeutics

7 April 2026 - US biopharmaceutical companies Neurocrine Biosciences Inc (Nasdaq:NBIX) and Soleno Therapeutics Inc (Nasdaq:SLNO) announced on Monday that Neurocrine has entered into a definitive agree...

M2 Pharma
via M2 Pharma
ShareRead original

Read the full article at M2 Pharma →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

M2 Pharma
M2 Pharma
NewsDataUS

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Greensprings graduates demonstrate diverse pathways to success
Next
It Ends With Us star responds to judge's ruling in sexual harassment lawsuit

Related Articles

New CEO for Environmental Protection AuthorityScience
New CEO for Environmental Protection Authority
Unknown-just now-1 sources
Amid Iran war, 53 of Israel's future scientists showcase projects in Jerusalem contestScience
Amid Iran war, 53 of Israel's future scientists showcase projects in Jerusalem contest
Judy Siegel-Itzkovich-just now-1 sources
Primal Queen vs Her Bodhi reviews (2026): Why Her Bodhi is a science-backed alternative?Science
Primal Queen vs Her Bodhi reviews (2026): Why Her Bodhi is a science-backed alternative?
David Rabinowicz-20m ago-1 sources